USAN Watch: February 2013
| USAN | Research Code | Structure | Drug Class | Therapeutic class | Target |
| avarofloxacin |
JNJ-Q2, JNJ-32729463-AAA
| synthetic small molecule | therapeutic | topo II | |
| dianexin | ASP-8597 | protein | therapeutic | ||
| eldelumab |
BMS-936557, MDX-1100
| monoclonal antibody | therapeutic | CXCL10 | |
| eluxadoline |
JNJ-27018966
| synthetic small molecule | therapeutic | mu Opioid R, delta Opioid R | |
| formofilcon A | polymer | contact lens polymer | n/a | ||
| galunisertib |
LY-2157299
| synthetic small molecule | therapeutic | TGFBetaR1 TGFBetaR2 | |
| guselkumab |
CNTO-1959
| monoclonal antibody | therapeutic | IL23 | |
| ledipasvir | GS-5885 | synthetic small molecule | therapeutic | HCV NS5A | |
| liafensine | BMS-820836 | synthetic small molecule | therapeutic | ||
| margetuximab |
MGAH22
| monoclonal antibody | therapeutic | ERBB2 | |
| mavatrep |
JNJ-39439335
| synthetic small molecule | therapeutic | ||
| methylsamidorphan |
ALKS-37, RDC-1036-00
| natural product-derived small molecule | therapeutic | Opioid receptors | |
| palbociclib |
PD-0332991
| synthetic small molecule | therapeutic | CDK4 CDK6 | |
| pegbovigrastim |
LY-2953726
| protein | therapeutic | CSFR | |
| pevonedistat | MLN-4924 | synthetic small molecule | therapeutic | NAE | |
| quilizumab |
RG-7449, MEP-1972A, Anti-M1’, Anti-M1 prime
| monoclonal antibody | therapeutic | IgE M1' | |
| sisapronil | PF-0241851 | synthetic small molecule | therapeutic | ||
| technetium Tc 99m trofolastat |
MIP-Tc-1404, MIP-99mTc-1404
| synthetic small molecule | imaging agent | PSMA | |
| tovetumab | MEDI-575 | monoclonal antibody | therapeutic | PDGFRa | |
| vantictumab |
OMP-18R5
| monoclonal antibody | therapeutic | Frizzled | |
| vatiquinone | EPI-743 | synthetic small molecule | therapeutic | NQO1 | |
| vedroprevir | GS-9451 | synthetic small molecule | therapeutic | HCV NS3 PR |
jpo